1. Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma
    Yongxu Zhou et al, 2023, Frontiers in Pharmacology CrossRef
  2. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury
    Grigorios Christidis et al, 2021, International Journal of Molecular Sciences CrossRef
  3. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach
    Eskezeia Yihunie Dessie et al, 2021, International Journal of Molecular Sciences CrossRef
  4. Transcriptomic identification of HBx-associated hub genes in hepatocellular carcinoma
    Zhengzhong Ni et al, 2021, PeerJ CrossRef
  5. Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma
    Xinran Tang et al, 2022, Frontiers in Immunology CrossRef
  6. Modulating effect of Cu(II) complexes with enamine and tetrazole derivatives on CYP2C and CYP3A and their cytotoxic and antiproliferative properties in HepG2 spheroids
    L. S. Klyushova et al, 2022, Acta Biomedica Scientifica CrossRef
  7. BrcaDx: precise identification of breast cancer from expression data using a minimal set of features
    Sangeetha Muthamilselvan et al, 2023, Frontiers in Bioinformatics CrossRef
  8. Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target
    Takashi Motomura et al, 2021, Journal of Personalized Medicine CrossRef
  9. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis
    Jianhua Wu et al, 2021, Frontiers in Genetics CrossRef
  10. The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes
    Dong Gui Hu et al, 2020, Cancers CrossRef
  11. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome
    Dan Li et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef